In a report released today, Geulah Livshits from Chardan Capital reiterated a Buy rating on Iovance Biotherapeutics Inc (IOVA –
Category: Healthcare
Iovance Biotherapeutics Inc (IOVA) Gets a Buy Rating from B.Riley FBR
B.Riley FBR analyst George Zavoico maintained a Buy rating on Iovance Biotherapeutics Inc (IOVA – Research Report) on May 17
Medicines Co (MDCO) Receives a Buy from B.Riley FBR
B.Riley FBR analyst Mayank Mamtani maintained a Buy rating on Medicines Co (MDCO – Research Report) today and set a
Mirati Therapeutics (MRTX) Gets a Buy Rating from JonesTrading
In a report issued on May 16, Soumit Roy from JonesTrading maintained a Buy rating on Mirati Therapeutics (MRTX –
Analysts Conflicted on These Healthcare Names: Moleculin Biotech (NASDAQ: MBRX) and Masimo Corp (NASDAQ: MASI)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Moleculin Biotech (MBRX – Research
Needham Believes Zealand Pharma A/S (NASDAQ: ZEAL) Won’t Stop Here
In a report issued on May 17, Alan Carr from Needham maintained a Buy rating on Zealand Pharma A/S (ZEAL
Noble Financial Thinks Electrocore Llc’s Stock is Going to Recover
Noble Financial analyst Ahu Demir reiterated a Buy rating on Electrocore Llc (ECOR – Research Report) on May 17 and